secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-10-28T23:59:59+00:00
Accession:  0001213900-25-102828
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical gets Nasdaq extension until Feb 23, 2026 to meet listing requirement
--------------------------------------------------------------------------------

- Nasdaq panel grants exception until Feb 23, 2026 to comply with $35M market value listing rule.
- Company cites recent equity raises, debt extinguishment, and FDA approval of final stage of Acclaim cochlear implant trial.
- Over 28 million shares outstanding; trading volume increased since trial expansion announcement.
- Company must promptly notify Nasdaq of any events affecting compliance during the exception period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025102828/0001213900-25-102828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025102828/ea0262700-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-102828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer